Association of a COVID-19 diagnosis with adverse events, cohort design, follow-up starting on the day after time 0. 著者: Shelby S. Fisher (22676406)

主題:

Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0. 著者: Shelby S. Fisher (22676406)

主題:

Eligibility assessment, covariate assessment, and follow-up windows relative to time 0 for the cohort design. 著者: Shelby S. Fisher (22676406)

主題:

Estimated Association of a COVID-19 Diagnosis With Neurologic or Immune-Mediated Outcomes: Analysis Starting Follow-Up on the Day After Time 0. 著者: Shelby S. Fisher (22676406)

主題:

Characteristics of included individuals for SCRI and cohort analyses. 著者: Shelby S. Fisher (22676406)

主題:

Analysis set for each outcome and definition. 著者: Shelby S. Fisher (22676406)

主題:

Eligibility Assessment, Covariate Assessment, Risk Windows, and Reference Windows Relative to Time 0 for the Self-Controlled Risk Interval Design. 著者: Shelby S. Fisher (22676406)

主題:

High-Throughput Mass Spectral Library Searching of Small Molecules in R with NIST MSPepSearch 著者: Andrey Samokhin (20282728)

主題: